Cargando…
Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
OBJECTIVE: Psychiatric symptoms and mental disorders are common after Coronavirus Disease-19 (COVID-19). Some drugs used to treat acute COVID-19 have psychiatric side effects. We assessed the psychiatric symptoms and mental disorders of patients treated for acute COVID-19 with hydroxychloroquine (HC...
Autores principales: | Gasnier, Matthieu, Choucha, Walid, Montani, David, Noël, Nicolas, Verstuyft, Céline, Radiguer, Francois, Monnet, Xavier, Becquemont, Laurent, Corruble, Emmanuelle, Colle, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606425/ https://www.ncbi.nlm.nih.gov/pubmed/36263650 http://dx.doi.org/10.9758/cpn.2022.20.4.762 |
Ejemplares similares
-
Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort
por: Faulet, Théo, et al.
Publicado: (2023) -
P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?
por: Gasnier, Matthieu, et al.
Publicado: (2022) -
Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022) -
128. Long Covid and Psychiatric Disorders 4 Months After a Hospitalization for COVID-19: A Cross Sectional Study
por: Gasnier, Matthieu, et al.
Publicado: (2023) -
Intra-nasal Esketamine Induced Psychotic Disorder in a Post Covid-19 Major Depressive Episode: a case report
por: Tang, Julie, et al.
Publicado: (2023)